SOURCES:
Sarah Bramblette, senior advocacy manager, Obesity Action Coalition (OAC), Miami.
Obesity Medicine Association: "Why Obesity is a Disease," "Weight Loss Medication and Pregnancy: Is It Safe?"
UpToDate: "Overweight and Obesity in Adults: Health Consequences."
Current Obesity Reports: "Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over."
National Institute of Diabetes and Digestive and Kidney Diseases: "Prescription Medications to Treat Overweight & Obesity," "Potential Candidates for Weight-loss Surgery."
National Association of Insurance Commissioners: "Does Insurance Cover Prescription Weight Loss Injectables? "
American Medical Association: "Questions patients may have about weight-loss drugs."
The New England Journal of Medicine: "Once-Weekly Semaglutide in Adults with Overweight or Obesity."
Mother to Baby, National Library of Medicine: "Tirzepatide (Mounjaro, Zepbound)."
Journal of Managed Care and Specialty Pharmacy: "Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes."
Journal of Psychiatric Research: "Obesity as a causal risk factor for depression: Systematic review and meta-analysis of Mendelian Randomization studies and implications for population mental health."
